Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. COST
2. AKAM
3. ZS
4. SPY
5. ULS
6. META
7. PRME
8. CLOV
9. DRI
10. CNP

Go back to Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology
(NASDAQ: PHVS) Delayed: 32.99 --0 (-0%)
Previous Close $32.99    52 Week High $ 
Open $32.99    52 Week Low $ 
Day High $32.99    P/E N/A 
Day Low $32.99    EPS $ 
Volume 519